1Meier P,Dayer E,Blanc E,et al.Early T cell activation correlates with expression of apoptosis markers in patients with end stage renal disease.J Am Soc Nephrol,2002,13:204-212
2Bonomini M,Sirolli V,Settefrati N,et al.Increased erythrocyte phosphatidylserine exposure in chronic renal failure.J Am Soc Nephrol,1999,10:1982-1990
4Bratosin D,Estaquier J,Petit F,et al.Programmed cell death in mature erythrocytes:A model for investigating death effector pathways operating in the absence of mitochondria.Cell Death Differ,2001,8:1143-1156
5Chung SH,Heimburger O,Stenvinkel P,et al.Association between residual renal function,inflammation and patient survival in new peritoneal dialysis patients.Nephrol Dial Transplant,2003,18:590-597
6Pearson TA,Mensah GA,Alexander RW,et al.Markers of inflammation and cardiovascular disease:Application to clinical and public health practice:A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.Circulation,2003,107:499-511
7Myssina S,Huber SM,Birka C,et al.Inhibition of erythrocyte cation channels by erythropoietin.J Am Soc Nephrol,2003,14:2750-2757
8Cole CH,Balfe JW,Welt LG.Induction of a ouabain-sensitive ATPase defect by uremic plasma.Trans Assoc Am Physicians,1968,81:213-220
9Perna A,Inggrosso D,Zappia V,et al.Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure.J Clin Invest,1993,91:2497-2503
10Grimm C,Wenzel A,Groszer M,et al.HIF-1-induced erythropoietin in the hypoxic retina protects against lightinduced retinal degeneration.Nat Med,2002,8:718-724
